Fancourt C - Search Results

1

Quantifying rates of glucose production in vivo following an intraperitoneal tracer bolus.

Wang SP, Zhou D, Yao Z, Satapati S, Chen Y, Daurio NA, Petrov A, Shen X, Metzger D, Yin W, Nawrocki AR, Eiermann GJ, Hwa J, Fancourt C, Miller C, Herath K, Roddy TP, Slipetz D, Erion MD, Previs SF, Kelley DE. Wang SP, et al. Among authors: fancourt c. Am J Physiol Endocrinol Metab. 2016 Dec 1;311(6):E911-E921. doi: 10.1152/ajpendo.00182.2016. Epub 2016 Sep 20. Am J Physiol Endocrinol Metab. 2016. PMID: 27651111 Free article.

2

Clinical Evaluation of MK-2640: An Insulin Analog With Glucose-Responsive Properties.

Krug AW, Visser SAG, Tsai K, Kandala B, Fancourt C, Thornton B, Morrow L, Kaarsholm NC, Bernstein HS, Stoch SA, Crutchlow M, Kelley DE, Iwamoto M. Krug AW, et al. Among authors: fancourt c. Clin Pharmacol Ther. 2019 Feb;105(2):417-425. doi: 10.1002/cpt.1215. Epub 2018 Sep 30. Clin Pharmacol Ther. 2019. PMID: 30125349 Clinical Trial.

3

A Model-Informed Drug Discovery and Development Strategy for the Novel Glucose-Responsive Insulin MK-2640 Enabled Rapid Decision Making.

Visser SAG, Kandala B, Fancourt C, Krug AW, Cho CR. Visser SAG, et al. Among authors: fancourt c. Clin Pharmacol Ther. 2020 Jun;107(6):1296-1311. doi: 10.1002/cpt.1729. Epub 2020 Feb 3. Clin Pharmacol Ther. 2020. PMID: 31889297 Free PMC article.

4

Assessment of Pharmacokinetic Interaction Between Letermovir and Fluconazole in Healthy Participants.

Adedoyin A, Fancourt C, Menzel K, Zhao T, Tomek C, Panebianco D, McCrea JB, Stoch SA, Iwamoto M. Adedoyin A, et al. Among authors: fancourt c. Clin Pharmacol Drug Dev. 2021 Feb;10(2):198-206. doi: 10.1002/cpdd.852. Epub 2020 Jul 22. Clin Pharmacol Drug Dev. 2021. PMID: 32700459 Clinical Trial.

5

Population pharmacokinetics of letermovir following oral and intravenous administration in healthy participants and allogeneic hematopoietic cell transplantation recipients.

Prohn M, Viberg A, Zhang D, Dykstra K, Davis C, Macha S, Sabato P, de Alwis D, Iwamoto M, Fancourt C, Cho CR. Prohn M, et al. Among authors: fancourt c. CPT Pharmacometrics Syst Pharmacol. 2021 Mar;10(3):255-267. doi: 10.1002/psp4.12593. Epub 2021 Mar 12. CPT Pharmacometrics Syst Pharmacol. 2021. PMID: 33440077 Free PMC article. Clinical Trial.

6

Exposure-Response Analyses of Letermovir Following Oral and Intravenous Administration in Allogeneic Hematopoietic Cell Transplantation Recipients.

Prohn M, Cho CR, Viberg A, Dykstra K, Davis C, Sabato P, Stone J, Badshah C, Murata Y, Leavitt R, Fancourt C, Macha S. Prohn M, et al. Among authors: fancourt c. Clin Pharmacol Ther. 2022 Feb;111(2):485-495. doi: 10.1002/cpt.2456. Epub 2021 Nov 29. Clin Pharmacol Ther. 2022. PMID: 34674258 Clinical Trial.

7

Acute and Chronic Effects of Rifampin on Letermovir Suggest Transporter Inhibition and Induction Contribute to Letermovir Pharmacokinetics.

Robbins JA, Menzel K, Lassman M, Zhao T, Fancourt C, Chu X, Mostoller K, Witter R, Marceau West R, Stoch SA, McCrea JB, Iwamoto M. Robbins JA, et al. Among authors: fancourt c. Clin Pharmacol Ther. 2022 Mar;111(3):664-675. doi: 10.1002/cpt.2510. Epub 2022 Jan 15. Clin Pharmacol Ther. 2022. PMID: 34888851

8

Pharmacokinetics, Safety, and Tolerability of Letermovir Following Single- and Multiple-Dose Administration in Healthy Japanese Subjects.

Asari K, Ishii M, Yoshitsugu H, Wakana A, Fancourt C, Yoon E, Furihata K, McCrea JB, Stoch SA, Iwamoto M. Asari K, et al. Among authors: fancourt c. Clin Pharmacol Drug Dev. 2022 Aug;11(8):938-948. doi: 10.1002/cpdd.1081. Epub 2022 Mar 2. Clin Pharmacol Drug Dev. 2022. PMID: 35238179 Clinical Trial.

9

Phase I Trial of the Human Double Minute 2 Inhibitor MK-8242 in Patients With Advanced Solid Tumors.

Wagner AJ, Banerji U, Mahipal A, Somaiah N, Hirsch H, Fancourt C, Johnson-Levonas AO, Lam R, Meister AK, Russo G, Knox CD, Rose S, Hong DS. Wagner AJ, et al. Among authors: fancourt c. J Clin Oncol. 2017 Apr 20;35(12):1304-1311. doi: 10.1200/JCO.2016.70.7117. Epub 2017 Feb 27. J Clin Oncol. 2017. PMID: 28240971 Free PMC article. Clinical Trial.

10

Transforming Translation Through Quantitative Pharmacology for High-Impact Decision Making in Drug Discovery and Development.

Gupta N, Bottino D, Simonsson USH, Musante CJ, Bueters T, Rieger TR, Macha S, Chenel M, Fancourt C, Kanodia J, Nayak S. Gupta N, et al. Among authors: fancourt c. Clin Pharmacol Ther. 2020 Jun;107(6):1285-1289. doi: 10.1002/cpt.1667. Epub 2019 Nov 10. Clin Pharmacol Ther. 2020. PMID: 31709519 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page